HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Mark J Millan Selected Research

Antiparkinson Agents (Antiparkinsonian Agents)

2/2011Differential induction of adenylyl cyclase supersensitivity by antiparkinson drugs acting as agonists at dopamine D1/D2/D3 receptors vs D2/D3 receptors only: parallel observations from co-transfected human and native cerebral receptors.
12/2009Heterodimerization of dopamine receptors: new insights into functional and therapeutic significance.
11/2002Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Mark J Millan Research Topics

Disease

13Parkinson Disease (Parkinson's Disease)
06/2013 - 11/2002
12Schizophrenia (Dementia Praecox)
09/2015 - 04/2005
6Dyskinesias (Dyskinesia)
10/2015 - 06/2004
5AIDS-Related Complex (ARC)
11/2012 - 04/2004
4Substance-Related Disorders (Drug Abuse)
12/2014 - 03/2009
3Neurobehavioral Manifestations
01/2014 - 04/2005
2Parkinsonian Disorders (Parkinsonism)
10/2015 - 11/2006
2Anxiety Disorders (Anxiety Disorder)
05/2015 - 06/2003
2Memory Disorders (Memory Loss)
12/2014 - 05/2012
2Thymoma (Thymic Carcinoma)
06/2013 - 03/2012
2Hypothermia
11/2011 - 02/2008
2Mood Disorders (Mood Disorder)
09/2011 - 10/2009
2Gambling (Pathological Gambling)
02/2011 - 12/2009
2Hypokinesia (Bradykinesia)
02/2010 - 06/2004
2Central Nervous System Diseases (CNS Diseases)
09/2008 - 12/2005
1Major Depressive Disorder (Major Depressive Disorders)
09/2015
1Nervous System Diseases (Neurological Disorders)
05/2015
1Fever (Fevers)
11/2011
1Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
02/2011
1Cocaine-Related Disorders (Cocaine Addiction)
03/2009
1Catalepsy
03/2008
1Amnesia (Dissociative Amnesia)
01/2008
1Hyperkinesis
11/2006
1Hallucinations (Hallucination)
04/2005
1Neuroblastoma
11/2004
1Depressive Disorder (Melancholia)
10/2004

Drug/Important Bio-Agent (IBA)

8Levodopa (L Dopa)FDA LinkGeneric
10/2015 - 06/2004
7Dopamine (Intropin)FDA LinkGeneric
10/2015 - 11/2006
7Serotonin (5 Hydroxytryptamine)IBA
05/2014 - 11/2002
6Messenger RNA (mRNA)IBA
11/2012 - 04/2004
4Brain-Derived Neurotrophic Factor (BDNF)IBA
06/2012 - 04/2004
4N- (4- (2- (8- cyano- 1,3a,4,9b- tetrahydro(1)benzopyrano(3,4- c)pyrrol- 2(3H)- yl)ethyl)phenyl)acetamideIBA
03/2009 - 02/2008
3LigandsIBA
05/2013 - 02/2010
3N-Methylaspartate (NMDA)IBA
02/2013 - 04/2005
3Norepinephrine (Noradrenaline)FDA LinkGeneric
06/2012 - 04/2004
3venlafaxine (Effexor)FDA LinkGeneric
06/2012 - 04/2004
3Antiparkinson Agents (Antiparkinsonian Agents)IBA
02/2011 - 11/2002
3Dopamine D3 ReceptorsIBA
08/2009 - 04/2005
3S 32504IBA
12/2006 - 06/2004
3Antidepressive Agents (Antidepressants)IBA
10/2004 - 04/2004
2AMPA Receptors (AMPA Receptor)IBA
10/2015 - 11/2012
2Oxidopamine (6 Hydroxydopamine)IBA
10/2015 - 02/2010
2S 20098 (agomelatine)IBA
05/2015 - 10/2009
2Corticotropin-Releasing HormoneIBA
12/2014 - 10/2014
2Cocaine (Cocaine HCl)IBA
12/2014 - 03/2012
2Carbon MonoxideIBA
01/2014 - 11/2010
2TachykininsIBA
01/2014 - 12/2005
2Phosphotransferases (Kinase)IBA
06/2013 - 03/2012
2Sirolimus (Rapamycin)FDA Link
06/2013 - 10/2012
2metabotropic glutamate receptor 5IBA
02/2013 - 11/2012
2Dizocilpine Maleate (Dizocilpine)IBA
02/2013 - 11/2012
2Antipsychotic Agents (Antipsychotics)IBA
10/2012 - 04/2005
2pramipexol (pramipexole)FDA LinkGeneric
02/2011 - 11/2004
2Piribedil (Trivastal)IBA
11/2010 - 11/2006
2Histamine (Histamine Dihydrochloride)FDA Link
05/2008 - 11/2002
21- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
12/2006 - 11/2006
21- (1- dimethylaminomethyl- 5- methoxybenzocyclobutan- 1- yl)cyclohexanolIBA
07/2004 - 04/2004
2CyclohexanolsIBA
07/2004 - 04/2004
1Trace amine-associated receptor 1IBA
10/2015
1Biological Markers (Surrogate Marker)IBA
09/2015
1Lysergic AcidIBA
05/2014
1Hallucinogens (Psychedelics)IBA
05/2014
15-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
05/2014
1Mescaline (Peyote)IBA
05/2014
1diethylamineIBA
05/2014
1NeuropeptidesIBA
11/2013
1Oxytocin (Pitocin)FDA LinkGeneric
11/2013
1NicotineFDA Link
06/2013
1Protein Kinases (Protein Kinase)IBA
06/2013
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
11/2012
1Glutamate Receptors (Glutamate Receptor)IBA
11/2012
1metabotropic glutamate receptor 2IBA
11/2012
12-methoxyidazoxanIBA
11/2012
1atipamezoleIBA
11/2012
1GYKI 52466IBA
11/2012
1LY 341495IBA
11/2012
1serotonin 6 receptorIBA
10/2012
1Phencyclidine (Angel Dust)IBA
10/2012
1Carisoprodol (Soma)FDA LinkGeneric
03/2012
1N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA
11/2011
1MicroRNAs (MicroRNA)IBA
02/2011
1S 33084IBA
02/2010
1hydroxide ionIBA
02/2008
1tetralinIBA
02/2008
1Scopolamine (Hyoscine)FDA Link
01/2008
1Dopamine Agonists (Dopamine Agonist)IBA
02/2007
1Reserpine (Serpasil)FDA Link
11/2006
1Adrenergic Receptors (Adrenergic Receptor)IBA
11/2006
1methoxyphenyl piperazinylIBA
11/2006
1Dopamine Receptors (Dopamine Receptor)IBA
11/2006
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
04/2005
1Glycine (Aminoacetic Acid)FDA LinkGeneric
04/2005
1GABA-A Receptors (GABA(A) Receptor)IBA
06/2003
1Neurotransmitter Agents (Neurotransmitter)IBA
06/2003
1BenzodiazepinesIBA
06/2003
1Morphine (MS Contin)FDA LinkGeneric
04/2002

Therapy/Procedure

1Drug Therapy (Chemotherapy)
05/2015
1Self Administration (Administration, Self)
03/2009
1Complementary Therapies (Alternative Medicine)
06/2003
1Analgesia
04/2002